Hypoglycemic activity of extracts of Chamaecyparis obtusa var. formosana leaf in rats with hyperglycemia induced by high-fat diets and streptozotocin

10.1016/j.jtcme.2019.11.003

Chia-Yun Hsu；Gong-Min Lin；Shang-Tzen Chang

Anti-diabetic activity ； Anti-obesity activity ； Chamaecyparis obtusa var. formosana ； Disaccharidases ； Proanthocyanidins ； Protein tyrosine phosphatases

Journal of Traditional and Complementary Medicine

10卷4期（2020 / 07 / 01）

389 - 395

英文

Chamaecyparis obtusa var. formosana is a species indigenous to Taiwan and has been used as a medicinal plant. It has been claimed that the hot water extracts of C. obtusa var. formosana leaves (CoLE) with flavonoids and proanthocyanidins have anti-oxidant and anti-hyperglycemic activities in vitro. This study further examines the anti-hyperglycemic activity of CoLE and its possible mechanisms in hyperglycemic rats. Hyperglycemia of rats was induced by streptozotocin (STZ) and high-fat diets (HFD). Hyperglycemic rats treated orally with 30 and 150 mg/kg CoLE were classified into LCO and HCO groups, respectively. After three-month treatment, both LCO and HCO groups showed improved glucose metabolism in oral glucose tolerance and postprandial blood glucose tests. Decrease in HOMA-IR, leptin and adiponectin levels of the HCO group revealed amelioration of insulin and leptin resistance. Obesity and accumulation of visceral fats induced by STZ and HFD could be alleviated in both HCO and LCO groups. These anti-diabetic effects might be contributed by inhibition of intestinal digested enzymes and protein tyrosine phosphatases (PTPases). Although other studies are necessary, these findings suggest that CoLE could be potentially used as a health complement for treating diabetes without significant toxicity.

1. American Diabetes Association(2018).5. Prevention or delay of type 2 diabetes standards of medical care in diabetes-2018.Diabetes Care,41,S51-S54.
2. American Diabetes Association(2018).2. Classification and diagnosis of diabetes standards of medical care in diabetes-2018.Diabetes Care,41,S13-S27.
3. Buchholz, T,Melzig, MF(2015).Polyphenolic compounds as pancreatic lipase inhibitors.Planta Med,81,771-783.
4. Buse, JB,Kaufman, FR,Linder, B,Hirst, K,Ghormli, LE,Willi, D(2013).Diabetes screening with hemoglobin A1c versus fasting plasma glucose in a multiethnic middleschool cohort.Diabetes Care,36,429-435.
5. Cheng, SC,Li, WH,Shi, YC(2015).Antioxidant activity and delayed aging effects of hot water extract from Chamaecyparis obtusa var. formosana leaves.J Agric Food Chem,62,4159-4165.
6. Cho, NH,Shaw, JE,Karuranga, S(2018).IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045.Diabetes Res Clin Pract,138,271-281.
7. Cremonini, E,Bettaieb, A,Haj, FG,Fraga, CG,Oteiza, PI(2015).(-)-Epicatechin improves insulin sensitivity in high fat diet-fed mice.Arch Biochem Biophys,599,13-21.
8. Dahlqvist, A.(1968).Assay of intestinal disaccharidases.Anal Biochem,22,99-107.
9. Deng, YX,Zhang, XJ,Shi, QZ,Chen, YS,Qiu, XM,Chen, B(2012).Anti-hyperglycemic effects and mechanism of traditional Chinese medicine Huanglian Wan in streptozocin-induced diabetic rats.J Ethnopharmacol,144,425-432.
10. Fernandez-Ruiz, R,Vieira, E,Garcia-Roves, PM,Gomis, R(2015).Protein tyrosine phosphatase-1B modulates pancreatic beta-cell mass.PLoS One,9,e90344.
11. Ferrannini, E,Mari, A.(2014).β-Cell function in type 2 diabetes.Metabolism,63,1217-1227.
12. Frazier, RA,Deaville, ER,Green, RJ(2010).Interactions of tea tannins and condensed tannins with proteins.J Pharm Biomed Anal,51,490-495.
13. Governa, P,Baini, G,Borgonetti, V(2018).Phytotherapy in the management of diabetes: a review.Molecules,23,105.
14. Gurzov, EN,Stanley, WJ,Brodnicki, TC,Thomas, HE(2015).Protein tyrosine phosphatases: molecular switches in metabolism and diabetes.Trends Endocrinol Metab,26,30-39.
15. Hsu, CY,Lin, GM,Lin, HY,Chang, ST(2018).Characteristics of proanthocyanidins in leaves of Chamaecyparis obtusa var. formosana as strong α-glucosidase inhibitors.J Sci Food Agric.,98,3806-3814.
16. Joshi, SR,Standl, E,Tong, N,Shah, P,Kalra, S,Rathod, R(2015).Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review.Expert Opin Pharmacother,16,1959-1981.
17. Jurgoński, A,Juśkiewicz, J,Zduńczyk, Z(2008).Ingestion of black chokeberry fruit extract leads to intestinal and systemic changes in a rat model of prediabetes and hyperlipidemia.Plant Foods Hum Nutr,63,176-182.
18. Kim, DL,Kim, SD,Kim, SK,Park, S,Song, KH(2016).Is an oral glucose tolerance test still valid for diagnosing diabetes mellitus?.Diabetes Metab J.,40,118-128.
19. Lin, GM,Lin, HY,Hsu, CY,Chang, ST(2016).Structural characterization and bioactivity of proanthocyanidins from indigenous cinnamon (Cinnamomum osmophloeum).J Sci Food Agric.,96,4749-4759.
20. Liu, CY,Huang, CJ,Huang, LH,Chen, IJ,Chiu, JP,Hsu, CH(2014).Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebocontrolled trial.PLoS,9,e91163.
21. Liu, L,Yu, YL,Liu, C,Wang, XT,Liu, XD,Xie, L(2011).Insulin deficiency induces abnormal increase in intestinal disaccharidase activities and expression under diabetic states, evidences from in vivo and in vitro study.Biochem Pharmacol,82,1963-1970.
22. Malongane, F,McGaw, LJ,Mudau, FN(2017).The synergistic potential of various teas, herbs and therapeutic drugs in health improvement: a review.J Sci Food Agric.,97,4679-4689.
23. Orhan, N,Orhan, DD,Gökbulut, A,Aslan, M,Ergun, F(2014).Comparative analysis of chemical profile, antioxidant, in-vitro and in-vivo antidiabetic activities of Juniperus foetidissima Willd. and Juniperus sabina L.Iran J Pharm Res,16,64-74.
24. Reilly, SM,Saltiel, AR(2017).Adapting to obesity with adipose tissue inflammation.Nat Rev Endocrinol,13,633-643.
25. Shan, MQ,Shang, J,Ding, AW(2014).Platycladus orientalis leaves: a systemic review on botany, phytochemistry and pharmacology.Am J Chin Med.,42,523-542.
26. Stern, JH,Rutkowski, JM,Scherer, PE(2016).Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk.Cell Metabol,23,770-784.
27. Stodt, U,Engelhardt, UH(2013).Progress in the analysis of selected tea constituents over the past 20 years.Food Res Int,53,636-648.
28. Tavaresa, L,McDougall, GJ,Fortalezas, S,Stewart, RD,Ferreira, B,Santos, CN(2012).The neuroprotective potential of phenolic-enriched fractions from four Juniperus species found in Portugal.Food Chem,135,562-570.
29. Veerapur, VP,Prabhakar, KR,Thippeswamy, BS,Bansal, P,Srinivasan, KK,Unnikrishnan, MK(2012).Antidiabetic effect of Ficus racemosa Linn. stem bark in high-fat diet and low-dose streptozotocin-induced type 2 diabetic rats: a mechanistic study.Food Chem,132,186-193.
30. Wang, CD,Teng, BS,He, YM(2012).Effect of a novel proteoglycan PTP1B inhibitor from Ganoderma lucidum on the amelioration of hyperglycaemia and dyslipidaemia in db/db mice.Br J Nutr,108,2014-2025.
31. Xu, J,Wang, X,Yue, J,Sun, Y,Zhang, X,Zhao, Y(2018).Polyphenols from acorn leaves (Quercus liaotungensis) protect pancreatic beta cells and their inhibitory activity against α-glucosidase and protein tyrosine phosphatase 1B.Molecules,23,2167-2178.
32. Yang, K,Chan, CB(2017).Proposed mechanisms of the effects of proanthocyanidins on glucose homeostasis.Nutr Rev.,75,642-657.
33. Zhou, X,Chen, S,Ye, X(2017).The anti-obesity properties of the proanthocyanidin extract from the leaves of Chinese bayberry (Myrica rubra Sieb.et Zucc.).Food Funct,8,3259-3270.

1. (2024).Response surface methodology based development of an optimized polyherbal formulation and evaluation of its anti-diabetic and anti-obesity potential in high-fat diet-induced obese mice.Journal of Traditional and Complementary Medicine,14(1),70-81.